Jul. 13 at 6:19 PM
$RMTI @Stock_Catcher
Rockwell Medical is navigating short-term headwinds due to customer loss, but holds steady on margins and outlook. With product innovation and a clear global growth path, analysts are optimistic, seeing potential for strong recovery and upside from current levels.
With Q2 due no later than 14th/18th August, just over a month away, this SP isn't going to remain at these levels for long with some estimating a potential 250% gain back up to
$4.
With news and some more volume this could easily run.
Look at the chart SC. Do you see what I see? 👀
💵🐍
